Research and Data Insights
The article below outlines the development and initial implementation of a training program for a Community Health Worker role, designed as part of a clinical trial targeting the specific needs of transition-age emerging adults with sickle cell disease. The program adapts the Individualized Management for Patient-Centered Targets (IMPaCT) CHW model to this population.
The transition from pediatric to adult-oriented care is often challenging for adolescents with sickle cell disease. While the need for structured transition programs is well recognized, many patients leave pediatric care without adequate preparation. The article below evaluates the preparedness of adolescent sickle cell disease patients for this transition and identifies key factors that predict readiness.
Myth vs. Fact
Myth: The transition from pediatric to adult healthcare is typically unimportant and has little impact on an adolescent’s overall development.
Fact: Transition to adulthood is a vulnerable time for emerging adults (16–25 years of age) with sickle cell disease, as there is a seven-fold increase in mortality rates during the transition period.